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Odonto-onycho-dermal dysplasia (OODD), a rare autosomal-recessive inherited form of ectodermal dysplasia including severe oligodon-
tia, nail dystrophy, palmoplantar hyperkeratosis, and hyperhidrosis, was recently shown to be caused by a homozygous nonsense
WNT10A mutation in three consanguineous Lebanese families. Here, we report on 12 patients, from 11 unrelated families, with ecto-
dermal dysplasia caused by ﬁve previously undescribed WNT10Amutations. In this study, we show that (1) WNT10Amutations cause
not only OODD but also other forms of ectodermal dysplasia, reaching from apparently monosymptomatic severe oligodontia to
Scho¨pf-Schulz-Passarge syndrome, which is so far considered a unique entity by the ﬁndings of numerous cysts along eyelid margins
and the increased risk of benign and malignant skin tumors; (2) WNT10A mutations are a frequent cause of ectodermal dysplasia
and were found in about 9% of an unselected patient cohort; (3) about half of the heterozygotes (53.8%) show a phenotype manifes-
tation, including mainly tooth and nail anomalies, which was not reported before in OODD; and (4) heterozygotes show a sex-biased
manifestation pattern, with a signiﬁcantly higher proportion of tooth anomalies in males than in females, whichmay implicate gender-
speciﬁc differences of WNT10A expression.The ectodermal dysplasias (EDs) are a large, heterogeneous,
and growing group of disorders characterized by defects in
morphogenesis of skin, hair, nails, teeth, and sweat, seba-
ceous, submucous, and mammary glands. Numerous,
more or less distinct entities of ectodermal dysplasia,
including syndromal forms and monosymptomatic oligo-
dontia as well, have been reported. Most of them are
very rare, and their cause is often unknown.
Recently, Adaimy et al.1 identiﬁed a homozygous
nonsense WNT10A (MIM 606268) mutation (c.697G>T
[p.E233X]) as the cause of autosomal-recessive odonto-ony-
cho-dermal dysplasia (OODD [MIM 257980]) in three
consanguineous Lebanese families. OODD was ﬁrst
described by Fadhil et al.2 and was further delineated by
others3–5 as a distinct rare condition characterized by severe
oligodontia, nail dystrophy, hypotrichosis, erythematous
lesions of face, smooth tongue with reduced fungiform
and ﬁliform papillae, and palmoplantar hyperkeratosis
with increased sweating. Additional single-case reports of
apparentlydifferent formsofEDs, eitherwithaquite similar
phenotype but no distinct symptoms distinguishing them
from OODD6,7 or with additional unique symptoms of
numerous cysts along eyelidmargins in Scho¨pf-Schulz-Pas-
sarge syndrome (SSPS [MIM 224750]),8–16 were published.
Until now, the cause of SSPS was unknown and genetic
heterogeneity was discussed on the basis of an apparent
autosomal-recessive as well as autosomal-dominant mode
of inheritance.
OODD is considered a rare condition, and no reports
were published of WNT10A-related ED except the one byTheAdaimy et al.1 However, because phenotypic variability
was observed in these families, we wondered whether
WNT10A mutations might explain a broader spectrum of
EDs. Therefore, we screened theWNT10A gene in patients
with clinical ﬁndings resembling OODD or SSPS or with
unclassiﬁed forms of ED. All patients and their relatives
who were genotyped consented to participate in our study
on ED and oligodontia, which was sanctioned by an inde-
pendent institutional ethics committee in accordance with
the national regulations and GCP/ICH guidelines. All
index patients and their relatives were ascertained by
physician-initiated referral or had contacted us indepen-
dently via the German ED support group. Clinical data
were obtained by an examination performed by one of
us, through questionnaires, or from medical records. All
index patients were prescreened for the absence of EDA
(MIM 300451) mutations (data not shown). DNA was iso-
lated from peripheral blood leukocytes via standard proce-
dures. PCR was performed with speciﬁc primer pairs (Table
S1, available online) selected with Primer3 and checked
with MFOLD and SNPCheck. The PCR products were
treated with ExoSAP-IT (USB Corporation, Cleveland,
OH, USA), in accordance with the manufacture’s instruc-
tions, and sequenced with the BigDye Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems, Carlsbad, CA,
USA). Mutation screening was performed on a 3730 DNA
Analyzer (Applied Biosystems).
The WNT10A gene spans approximately 13.4 kb on
human chromosome 2q35, contains four exons, and
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of two domains: a signal peptide (amino acid position
1-35) and the Wnt domain (amino acid position 60-417).
Five previously undescribed nucleotide substitutions
within the coding region of the WNT10A gene were iden-
tiﬁed as causing different manifestations of ED in 12
patients from 11 unrelated families of German and Turkish
origin (for pedigree details, see Figure 1). Three of these
(c.27G>A [p.W9X], c.321C>A [p.C107X], and c.1128C>A
[p.C376X]) predicted premature termination of translation
and were found in index patients in either homozygous or
compound heterozygous state together with a missense
mutation. Two nucleotide substitutions (c.383G>A
[p.R128Q] and c.682T>A [p.F228I]) were shown to affect
amino acids from evolutionary highly conserved protein
regions (NCBI Protein Database) and were identiﬁed as
disease causing, because they were found to be associated
recurrently with a severe ED phenotype when occurring
in homozygous or compound heterozygous state together
with a nonsense mutation (Table 1; Figures S1 and S2).
Another previously undescribed nucleotide substitution
(c.493G>A [p.G165R]) (refSNP ID: ss131007345; dbSNP
database) probably represents a rare polymorphism, given
that it was found in trans position with the considered
pathogenetic mutation c.682T>A in two completely unaf-
fected individuals of family 123 (II:2 and II:3). In addition,
we found the already known SNP c.1087A>C (p.N363H)
(refSNP ID: rs34972707; dbSNP Database) in heterozygous
state in one unaffected relative of family 071 (III:3).
At least 200 control chromosomes of healthy, anony-
mized individuals from our institute’s registry (Mu¨nster
controls) were tested for each identiﬁed previously unde-
scribed nucleotide substitution by restriction enzyme anal-
ysis, high-resolutionmelting (HRM) analysis, or sequencing
(Table S2). For mutation restriction analysis, the PCR prod-
uctsweredigestedwith the speciﬁc restrictionendonuclease
(New England Biolabs, Frankfurt, Germany) at the recom-
mended conditions. For HRM analysis, primers for ampli-
fying an approximately 200 bp region surrounding the
different mutations were designed (Table S3). The PCR and
HRM analyses were performed on a LightCycler 480 (Roche
Diagnostics, Penzberg, Germany) with the LightCycler 480
High ResolutionMeltingMaster Kit (Roche Diagnostics), in
accordance with the manufacture’s instructions. DNA frag-
mentswith alteredmobilitywere sequenced. For eachof the
three nonsense mutations and the missense mutation
c.383G>A, no carrierswere foundwithin the control group.
The missense mutation c.682T>A, which is considered
disease causing by phenotypic consequences, was found
in two of 396 control chromosomes (~0.5%). The consid-
ered SNP c.493G>A (refSNP ID: ss131007345; dbSNP Data-
base) was found in 0.7% of the control chromosomes.
WNT10A belongs to a highly conserved gene family
encoding secreted signaling molecules. In general, WntTheproteins regulate cell-to-cell interactions and are implicated
in multiple developmental processes during embryogen-
esis, as well as in homeostasis in adult tissues by inhibiting
the b-catenin degradation complex and allowing interac-
tion with nuclear transcription factors LEF/TCF and regula-
tionof target gene expression17,18 (canonicalWnt signaling
pathway). In mouse and chicken embryos, Wnt10a
was shown to be upregulated in skin,19 in placodes at the
onset of hair folliclemorphogenesis, and in the oral epithe-
lium at the ﬁrst steps of tooth morphogenesis20–22 (mouse)
and was identiﬁed to be involved in the formation of the
apical ectodermal ridge during limb development23
(chicken).
The phenotypic expression in our patients with
WNT10A mutations shows a high degree of variability
(Table 1 and Figure S3); however, it is so far without recog-
nizable phenotype-genotype correlation. Hypohidrosis
(two patients) and hyperhidrosis (two patients) were re-
ported, and a change in sudation pattern from increased
to decreased could be observed in another patient with
puberty. Differences in sweat secretion in skin, palms,
and soles was described, including normal or decreased
ability to sweat in general but increased palmoplantar suda-
tion. Increased sweating only at night and discomfort at
temperatures above 25C were reported in one patient.
Nevertheless, most patients reported dry skin, which is
most likely caused by a decreased number of sebaceous
glands, as reported by Burket et al.9 and also conﬁrmed by
microscopic evaluation of a skin biopsy in one of our
patients. Nailsmay be normal, ﬂat, convex, thin, soft, split-
ting, slow growing, minimized, or apparently absent at
birth but starting to grow later in childhood, and they
may be differently affected regarding ﬁnger- and toenails
in the same patient. Palmoplantar skin showed dyshidrotic
blistering and peeling, hyperkeratotic plaques (which were
also reported on the dorsal ﬁngers), or severe hyperkeratosis
with painful lacerations, usually milder on palms than on
soles, in six patients but was normal in ﬁve patients. The
tongue was not studied in detail in our patients. However,
in photographs, the ﬁliform and fungiform papillae appear
to be reduced in at least two cases (Figure S4).
Overall,WNT10Amutations were found to cause a broad
continuum of phenotypes, ranging from apparently iso-
lated severe oligodontia with only very mild other ED
symptoms (patients 1 and 2), to several ‘‘variants’’ of
OODDwith or without facial skin erythema, palmoplantar
hyperkeratosis, or nail dysplasia, to SSPS in one patient
(patient 4), who also showed the typical ﬁnding of
numerous cysts along the upper and lower eyelid margins.
Her brother was reported to have similar symptoms but
a milder skin manifestation.
Photophobia, reported by Zirbel et al.4 as an unusual
symptom in one OODD patient, was also found in threeFigure 1. Pedigrees of 12 Patients with WNT10A-Related ED
Filled symbols indicate homozygous or compound heterozygous mutations; half-ﬁlled symbols indicate heterozygous mutations in
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Table 1. Clinical Symptoms and Mutational Results in 12 Patients with WNT10A Mutations
Patient 1 2 3 4 5 6 7 8 9 10 11 12
Family ID 008 008 088 100 032 071 122 112 073 121 115 123
Pedigree position III:10 III:12 III:4 II:4 III:1 II:1 III:13 III:1 III:3 IV:1 II:2 III:7
Clinical Symptoms
Eruption of ﬁrst teeth
at age
5mo. 5mo. 6mo. n.d. 7mo. n.d. n.d. 5mo. 4mo. 9mo. 10mo. n.d.
Primary teeth abnormal   þ þ  þ þ   þ þ 
Permanent teeth missing þ þ þ þ þ þ þ þ þ n.d. þ þ
Sparse scalp hair   þ þ  þ  þ þ þ þ 
Sparse body hair þ þ  þ þ þ  þ  n.d. n.d. n.d.
Sparse eyebrows þ þ þ   þ  þ  n.d. þ þ
Short eyelashes   þ   þ    n.d. þ þ
Hypohidrosis     þ þ    n.d.  þ
Hyperhidrosis    þ þ  þ   n.d.  
Dry skin   þ þ  þ  þ þ n.d. þ þ
Soft, thin skin    þ þ   þ n.d. n.d. n.d.
Palmar hyperkeratosis   (þ) þ  (þ)    n.d.  (þ)
Hyperkeratosis on
dorsal hands
   þ  þ    n.d. n.d. 
Plantar hyperkeratosis   þ þ þ þ    n.d.  
Palmoplantar sudation    þ  þ    n.d. þ 
Dyshidrotic blistering   n.d. þ  n.d.    n.d. þ 
Dystrophic ﬁngernails   þ þ þ (þ)   þ þ  
Dystrophic toenails   þ þ þ þ þ  þ þ þ 
Photophobia      þ  þ þ n.d.  
Lid cysts    þ      n.d.  
Mutational Results
Nucleotide substitution
(ﬁrst allele)a
c.321
C>A
c.321
C>A
c.321
C>A
c.321
C>A
c.321
C>A
c.1128
C>A
c.321
C>A
c.321
C>A
c.682
T>A
c.27
G>A
c.321
C>A
c.682
T>A
Nucleotide substitution
(second allele)a
c.383
G>A
c.383
G>A
c.321
C>A
c.321
C>A
c.321
C>A
c.1128
C>A
c.682
T>A
c.682
T>A
c.682
T>A
c.27
G>A
c.321
C>A
c.682
T>A
Amino acid
substitutions
p.C107X
p.R128Q
p.C107X
p.R128Q
p.C107X
p.C107X
p.C107X
p.C107X
p.C107X
p.C107X
p.C376X
p.C376X
p.C107X
p.F228I
p.C107X
p.F228I
p.F228I
p.F228I
p.W9X
p.W9X
p.C107X
p.C107X
p.F228I
p.F228I
þ: present; : not present; (þ): mild; n.d.: no data.
a According to GenBank NM_025216.2.of our patients. It might be caused by primary disturbed
retinal pigment epithelium (RPE) morphogenesis or failure
in photoreceptor protection in the degenerating retina.
There are some reasons to consider Wnt/b-catenin
signaling as an important pathway in RPE morphogenesis
via direct target genes such as Mitf, a key regulator of the
formation of pigment cells that transactivates promoters
of the tyrosinase gene family controlling pigment
synthesis. It is interesting to note that in the human
MITF gene (MIM 156845), mutations produce Waarden-
burg syndrome (MIM 193510), which is characterized by100 The American Journal of Human Genetics 85, 97–105, July 10, 2hypoplasia of iris stroma and hypopigmented ocular
fundus, inter alia. Decreased pigment synthesis might
also be the cause of the pale skin that was described as
a translucent appearance in patient 9 and the premature
graying of hair at age 14 in patient 1. A further indication
for the role ofWnt/b-catenin signaling in RPEmorphogen-
esis is the reverse observation that some variants of familial
adenomatous polyposis caused by APC gene (MIM 611731)
mutations show congenital nodular hyperpigmented RPE
lesions, indicating increased availability of b-catenin for
WNT signaling, given that the APC protein is a component009
Table 2. Tooth Findings in 11 Patients with WNT10A Mutations
Upper Right Upper Left
Patient
Family
ID
Pedigree
Position
Age
(yrs) 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28
1 008 III:10 15 - - þ - [-] þ - þ þ - [-] [-] [-] þ - -
2 008 III:12 10 - - þ [g] þ [-] ; ; ; ; [-] þ [g] - - -
3 088 III:4 11 - - - [-] [-] [-] - [-] [-] - [-] [-] [-] - - -
4 100 II:4 25 - - - [-] [-] - - - - - [-] [-] þ - - -
5 032 III:1 10 - - þ [g] - [-] - ; ; - [-] - [g] þ - -
6 071 II:1 28 Implants
7 122 III:13 12 - - þ [-] [-] [-] - þ þ - [-] [-] [-] þ - -
8 112 III:1 8 - þ - [g] [-] [g] [-] þ þ [-] [g] [-] [-] þ - -
9 073 III:3 18 - þ þ [-] [-] - ; þ þ ; - [-] [-] þ þ -
11 115 II:2 8 - - - [-] [-] [-] [-] [-] [-] [-] [-] [-] [-] - - -
12 123 III:7 12 - þ þ [-] þ - ; þ þ [-] [-] [-] [-] þ þ -
12 123 III:7 12 - þ þ [-] þ þ þ [-] [-] þ [-] [-] [-] þ þ g
11 115 II:2 8 - - - [-] [-] [-] [-] [-] [-] [-] [-] [-] [-] - - -
9 073 III:3 18 - - þ [-] þ þ þ - - þ þ þ þ þ þ -
8 112 III:1 8 - - þ [-] [-] [g] [-] [-] [-] [-] [g] [-] [-] þ - -
7 122 III:13 12 - - þ [-] þ þ þ þ þ þ þ [-] [-] þ - -
6 071 II:1 28 þ Implants þ
5 032 III:1 10 - - þ [-] - [-] [-] [-] [-] [-] [-] - [g] þ g -
4 100 II:4 25 - - - þ [-] [-] [-] [-] [-] [-] [-] [-] þ - - -
3 088 III:4 11 - - - [-] þ [-] [-] [-] [-] [-] [-] þ [-] - - -
2 008 III:12 10 - þ - [-] þ [-] [-] [-] [-] [-] þ þ [-] - þ -
1 008 III:10 15 - - þ [-] þ [-] [-] [-] [-] [-] [-] þ þ þ - -
Family
ID
Pedigree
Position
Age
(yrs)
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38
Lower Right Lower Left
‘‘Age’’ indicates age of patient when panoramic radiograph was taken.
18–11, 12–28, 48–41, and 31–38: tooth position according to the World Dental Federation [FDI] notation (ISO-3950 notation). In this two-digit numbering, the
first number represents a tooth’s quadrant (1, upper right; 2, upper left; 3, lower left; 4, lower right) and the second number represents the number of the tooth
from the midline of the face (1, central incisor; 2, lateral incisor; 3, canine; 4, first premolar; 5, second premolar; 6, first molar; 7, second molar; 8, wisdom tooth).
-: absent permanent tooth and tooth germ; [-]: deciduous tooth with absent permanent tooth germ; [g]: deciduous tooth with underlying permanent tooth
germ; g: permanent tooth germ; : conical tooth; þ: permanent tooth present.
A blank entry indicates that there was no information available.of the b-catenin APC-GSK3b-Axin destruction com-
plex24,25. Another explanation for the photophobia,
however, may come from the in vivo experiments in
mice performed by Yi et al.,26 who demonstrated Wnt10a
expression during cone photoreceptor degeneration in-
duced by oxidative stress, indicating prosurvival protec-
tion activity, a function that should get lost whenmutated.
However, none of the patients was examined by an
ophthalmologist for iris pigmentation or had an electrore-
tinogram for cone dystrophy. Thus, we suggest further
studies of the eyes in patients with WNT10A mutations
in order to possibly discover supportive data for one of
these hypotheses.The AEccrine poromas, basal cell carcinomas, and squamous
cell carcinoma were described in SSPS.10–12 In our patient
with SSPS (family 100-II:4), a porocarcinoma at the left
heel was also diagnosed. Because we identiﬁed SSPS as
part of the phenotypic spectrum, follow-up studies are
needed to ﬁnd out whether, like in SSPS, other phenotypes
with WNT10A mutations also have an increased skin
tumor risk.
The most consistent symptom in all cases, and, in our
opinion, the most speciﬁc diagnostic criterion, was the
severeoligodontia concerning thepermanent teeth (Table2
and Figure S4), with apparently normal (six patients) or
comparatively less disturbed deciduous dentition withmerican Journal of Human Genetics 85, 97–105, July 10, 2009 101
Table 3. Clinical Manifestation in Heterozygotes
Affected Structures
Substitution Sex
Family
ID
Pedigree
Position Teeth Nails Skin Hair
p.W6X Male 121 III:7 - - - S
p.W6X Female 121 III:8 - Y - L
p.W6X Female 121 III:10 A - - -
p.C107X Male 008 II:6 - Y H,D -
p.C107X Male 008 III:4 A Y K,P -
p.C107X Male 008 III:5 - - - -
p.C107X Male 008 III:11 - - - -
p.C107X Male 088 II:2 A - - -
p.C107X Male 100 II:1 B2 - - -
p.C107X Male 100 II:3 A - - -
p.C107X Male 032 II:2 G - - -
p.C107X Male 122 II:5 - - - -
p.C107X Male 122 II:6 C - - -
p.C107X Male 122 II:7 A - - -
p.C107X Male 115 I:1 - - - -
p.C107X Female 008 II:2 - - K -
p.C107X Female 088 II:3 - Y - -
p.C107X Female 032 II:3 - - - -
p.C107X Female 032 III:2 - - - -
p.C107X Female 112 II:3 - - - -
p.C107X Female 115 I:2 - - - -
p.R128Q Male 008 II:8 - - - -
p.R128Q Female 008 II:7 - - - E
p.F228I Male 122 II:10 A - - -
p.F228I Male 112 II:2 - - - -
p.F228I Male 073 II:1 - - K -
p.F228I Male 123 I:1 - - - -
p.F228I Male 123 II:2 - - - -
p.F228I Male 123 II:3 - - - -
p.F228I Male 123 II:4 B1 - - -
p.F228I Male 123 II:7 M - - -
p.F228I Male 123 II:8 - - - -
p.F228I Male 123 III:8 - - - -
p.F228I Female 122 II:8 - - - -
p.F228I Female 073 II:2 - Y - S
p.F228I Female 073 III:2 - - K -
p.F228I Female 123 I:4 M - - -
p.F228I Female 123 II:5 - - - -
p.C376X Male 071 I:1 - - - -
The use of a dash indicates that no abnormalities are present.102 The American Journal of Human Genetics 85, 97–105, July 10, 2conical frontal teeth or agenesis of the upper lateral or
central incisors (patients 3, 4, 6, 7, 10, and 11). These ﬁnd-
ings well reﬂect the importance ofWnt/b-catenin signaling
in tooth formation, especially the formation of succeda-
neous teeth.27
In SSPS, genetic heterogeneity was suggested on the
basis of observed both autosomal-recessive and auto-
somal-dominant modes of inheritance in different fami-
lies.8,13 In our opinion, however, mild symptoms, even if
multifocal, reﬂect heterozygous manifestations rather
than genetic heterogeneity. In fact, 21 out of 39 heterozy-
gous mutated relatives (53.8%) had minor disease-associ-
ated symptoms, such as abnormal shape or agenesis of
one or two (rarely up to six) permanent teeth, usually
upper lateral incisors, upper canines, or lower lateral or
central incisors, nail dystrophy, dry skin, palmoplantar
hyperkeratosis, sparce scalp hair, sparse eyelashes, or sparse
eyebrows (Table 3). The total frequency of heterozygotes
with any phenotypemanifestation differs nonsigniﬁcantly
between females (8/14; 57%) and males (13/25; 52%). In
all relatives with minor symptoms, the entire WNT10A
gene was sequenced, and in completely unaffected rela-
tives, a targeting mutational analysis was performed. All
individuals with minor symptoms were heterozygous for
one of the mutations described above, and none of the
tested relatives with two wild-type alleles had any symp-
toms. Phenotype manifestation in heterozygotes was not
described in the families reported by Adaimy et al.1
However, because the mutational spectrum in our patients
differs from the one mutation found by Adaimy et al.,1
a mutation-related phenotype in heterozygotes can not
be excluded.
Phenotypic manifestation in heterozygotes of an auto-
somal-recessive disorder is known from other conditions,
such as some metabolic diseases (e.g., congenital adrenal
hyperplasia [MIM 201910]28 and alpha-1-antitrypsin deﬁ-
ciency [MIM 107400])29,30 or bone dysplasias (e.g., oto-
spondylomegaepiphyseal dysplasia [OSMED] [MIM
215150]/Stickler syndrome type III [MIM 184840]).31 The
phenomenon was also described recently in EDAR [MIM
604095]-related hypohidrotic ED [MIM 224900], in which
‘‘some presumably recessive mutations may show pheno-
typic expression in carriers.’’32 Because of the high
frequency of clinical manifestation in heterozygotes seen
in our study, this possibility should also be conveyed
during counseling of individuals or families with
WNT10A-related ED.
Finally, another surprising result, which may provide
new insights into pattern formation in humans, came to
Teeth: A, markedly small, conical, sharp, or missing upper lateral permanent
incisors; G, all permanent teeth are markedly small; C, agenesis of upper
permanent canines; B1, agenesis of lower right central incisor; B2, agenesis
of both lower central incisors; M, agenesis of 2 to 6 permanent teeth except
third molars without further information available.
Nails: Y, nail dystrophy.
Skin: H, hypohidrosis; D, dry skin; K, hyperkeratosis of palms and/or soles; P,
laceration of finger tips.
Hair: S, sparse scalp hair; L, sparse eyelashes; E, sparse eyebrows.009
our attention: Whereas in homozygous or compound
heterozygous patients, no phenotypic differences
between males and females were evident, we found
a tendency of a sex-biased manifestation pattern in
heterozygous individuals. Thus, heterozygous males
predominantly showed agenesis or hypoplasia of perma-
nent upper lateral incisors (rarely canines or lower central
incisors) and less nail or hair manifestation than females.
This observation seems to be supported by family histo-
ries of additional male relatives with tooth anomalies
(family 088 [II:1]; family 100 [I:2]; family 121 [III:5 and
III:6]) and females with nail and hair anomalies (family
071 [I:1]; family 073 [I:4]) and by the literature.8,13
Thus, data were analyzed by Fisher’s exact test with SPSS
software version 17.0 for Windows (SPSS, Chicago, IL,
USA). Accordingly, in heterozygous individuals with
phenotypic manifestation, teeth of males were signiﬁcant
more frequently affected (10/13; 77%) than those of
females (2/8; 25%) (p ¼ 0.029) (Figure 2). Further studies
are necessary for the veriﬁcation of any sex-biased pheno-
typic expression in heterozygotes that would indicate that
haploinsufﬁciency in males and females has different
consequences as a result of tissue-speciﬁc sex-dependent
differences in WNT10A activity in the sense of a gender-
dependent micromodiﬁcation of the phenotype. In-
creasing evidence of the important functions of ﬁne-
tuning of signaling in tooth development comes from
the observation that premolar-like teeth in half of the
animals are present in mouse lines overexpressing ecto-
dysplasin.33 Moreover, it was very recently shown that
the number of teeth, as well as the molar cusp pattern,
can be modiﬁed by modulation of several different signal
pathways34 and that the stimulation of the Wnt pathway
in the oral epithelium leads to abundant de novo tooth
formation in transgenic mice.27 These ﬁndings support
the hypothesis that the diversity of tooth types and
numbers may have resulted from modiﬁcations of gene
expression within evolutionary conserved signal path-
ways, and one may also suspect that micromodulation
of gene expression is also responsible for many kinds of
Figure 2. Distribution of Involved Ecto-
dermal Structures in Heterozygous Mu-
tated Males and Females with Phenotypic
Manifestation
sexual dimorphism. Thus, a higher
concentration of an mRNA in one
sex, observed when the same tissue
is compared between the sexes, was
indeed designated as a major contrib-
utor to gender-speciﬁc differences in
gene expression.35,36 Conversely, it
can be assumed that the phenotypic
effect of loss-of-function mutations
of certain genes with different
gender-speciﬁc expression levels
may vary and would explain our ﬁndings of tooth abnor-
malities occurring predominantly in heterozygous males
and affecting mainly the upper lateral incisors.
Sexual dimorphism for human tooth size has been re-
ported in the general population,37,38 but although the
mechanism has become more obvious,34 the contributing
genes are still unknown. Our data may suggestWNT10A as
a good candidate for further research in this ﬁeld.
Agenesis or hypoplasia of permanent upper lateral inci-
sors is frequent in the population. Thus, Witkop39 stated
that the prevalence in the U.S. population is approxi-
mately 1:67 (1.5%). In at least part of the cases, an auto-
somal-dominant trait with reduced penetrance and vari-
able expression (selective tooth agenesis type 4; STHAG4
[MIM 150400]) was suggested, and in the supposed homo-
zygous state by parental consanguinity, adontia of perma-
nent teeth (MIM 206780) but unaffected primary denti-
tion was observed.39–44 Altogether, this pattern of tooth
anomalies is comparable to that which we found in the
patients and their relatives reported here. Thus, testing
for heterozygous WNT10A mutations in STHAG4 might
be worthwhile.
The frequency ofWNT10A-related ED in our cohort was
higher than expected from the rarely reported cases in the
literature. Although in our clientele of unselected patients
from 123 families with ED or isolated severe oligodontia,
mutational proven Christ-Siemens-Touraine syndrome
(CST [MIM 305100]) was the by far most common diag-
nosis (63/123, approximately 51%), homozygous or
compound heterozygousWNT10Amutations were identi-
ﬁed in patients from 11 of these 123 families (approxi-
mately 9%) representing 25% (11/44) of the genotyped
subgroup of index patients remaining after exclusion of
CST and other easily recognizable types of ED.
In conclusion, WNT10A mutation analysis might
become an important diagnostic test in many types of
ED with severe oligodontia concerning the permanent
teeth, with or without sweating problems, palmoplantar
hyperkeratosis, or nail and hair anomalies, that are now
difﬁcult to classify, as well as in isolated oligodontia.The American Journal of Human Genetics 85, 97–105, July 10, 2009 103
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